MODULAR MEDICAL, INC.: 10-Q filed 2020-11-09
What MODULAR MEDICAL, INC. reported in its quarterly report filed 2020-11-09 (fiscal Q2 2021): 26 published measures, 77 facts as tagged in accession 0001019056-20-000551.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2020-11-09
- Fiscal period
- fiscal Q2 2021
- Accession
- 0001019056-20-000551 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All MODULAR MEDICAL, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 2,199,398 | USD | |
| At 2020-03-31 | 3,858,551 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,291,908 | USD | |
| At 2020-03-31 | 980,129 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 907,490 | USD | |
| At 2020-06-30 | 2,467,615 | USD | |
| At 2020-03-31 | 2,878,422 | USD | |
| At 2019-09-30 | 4,555,076 | USD | |
| At 2019-06-30 | 5,546,287 | USD | |
| At 2019-03-31 | 6,474,057 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,486,574 | USD | |
| At 2020-03-31 | 3,122,134 | USD | |
| At 2019-09-30 | 4,775,706 | USD | |
| At 2019-03-31 | 6,553,768 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -1,860,729 | USD | 92 |
| 2020-04-01 to 2020-09-30 | -3,734,886 | USD | 183 |
| 2020-04-01 to 2020-06-30 | -1,874,157 | USD | 91 |
| 2019-07-01 to 2019-09-30 | -1,147,566 | USD | 92 |
| 2019-04-01 to 2019-09-30 | -2,269,764 | USD | 183 |
| 2019-04-01 to 2019-06-30 | -1,122,198 | USD | 91 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-09-30 | -3,029,671 | USD | 183 |
| 2019-04-01 to 2019-09-30 | -1,747,462 | USD | 183 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-09-30 | 93,303 | USD | 183 |
| 2019-04-01 to 2019-09-30 | 30,600 | USD | 183 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-09-30 | 1,487,414 | USD | 183 |
| 2019-04-01 to 2019-09-30 | 0 | USD | 183 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-04-01 to 2020-09-30 | -93,303 | USD | 183 |
| 2019-04-01 to 2019-09-30 | -30,600 | USD | 183 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | -12,303,920 | USD | |
| At 2020-03-31 | -8,569,034 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 1,600 | USD | 92 |
| 2020-04-01 to 2020-09-30 | 1,600 | USD | 183 |
| 2019-07-01 to 2019-09-30 | 0 | USD | 92 |
| 2019-04-01 to 2019-09-30 | 0 | USD | 183 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 342,299 | USD | |
| At 2020-03-31 | 301,308 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 300,604 | USD | 92 |
| 2020-04-01 to 2020-09-30 | 645,320 | USD | 183 |
| 2020-04-01 to 2020-06-30 | 344,716 | USD | 91 |
| 2019-07-01 to 2019-09-30 | 156,355 | USD | 92 |
| 2019-04-01 to 2019-09-30 | 350,783 | USD | 183 |
| 2019-04-01 to 2019-06-30 | 194,428 | USD | 91 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -1,859,178 | USD | 92 |
| 2020-04-01 to 2020-09-30 | -3,733,390 | USD | 183 |
| 2019-07-01 to 2019-09-30 | -1,157,341 | USD | 92 |
| 2019-04-01 to 2019-09-30 | -2,295,581 | USD | 183 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 1,522,072 | USD | |
| At 2020-03-31 | 3,186,293 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 733,207 | USD | |
| At 2020-03-31 | 661,393 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 214,359 | USD | |
| At 2020-03-31 | 367,019 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 1,859,178 | USD | 92 |
| 2020-04-01 to 2020-09-30 | 3,733,390 | USD | 183 |
| 2019-07-01 to 2019-09-30 | 1,157,341 | USD | 92 |
| 2019-04-01 to 2019-09-30 | 2,295,581 | USD | 183 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 1,092,665 | USD | 92 |
| 2020-04-01 to 2020-09-30 | 2,063,480 | USD | 183 |
| 2019-07-01 to 2019-09-30 | 633,241 | USD | 92 |
| 2019-04-01 to 2019-09-30 | 1,337,025 | USD | 183 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 18,600,158 | shares | |
| At 2020-03-31 | 17,870,261 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 13,192,810 | USD | |
| At 2020-03-31 | 10,505,592 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 235,027 | USD | |
| At 2020-03-31 | 270,950 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 365,468 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2020-09-30 | 105,000 | USD | |
| At 2020-03-31 | 140,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | -1,859,129 | USD | 92 |
| 2020-04-01 to 2020-09-30 | -3,733,286 | USD | 183 |
| 2019-07-01 to 2019-09-30 | -1,147,566 | USD | 92 |
| 2019-04-01 to 2019-09-30 | -2,269,764 | USD | 183 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2020-07-01 to 2020-09-30 | 766,513 | USD | 92 |
| 2020-04-01 to 2020-09-30 | 1,669,910 | USD | 183 |
| 2019-07-01 to 2019-09-30 | 524,100 | USD | 92 |
| 2019-04-01 to 2019-09-30 | 958,556 | USD | 183 |
Inspect the source
- Entity
- MODULAR MEDICAL, INC. / CIK 0001074871
- Captured
- 2026-09-20T05:20:05.018Z
- SEC response SHA-256
35d9c7a349fec6383baca56e8aa4820d6d19d2f4955371898b75285f3bf308e4
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001074871.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))